Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06286592 · ClinicalTrials.gov registry record · NA

LUNGevity: Lung Cancer Stigma Community Based Participatory Research

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT06286592: Completed NA study, sponsored by Rutgers, The State University of New Jersey.

NCT06286592 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06286592, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

Lung cancer survival rates are low for intersectional underserved groups. Lung cancer stigma and intersectional stigma related to minoritized group status leads to increased morbidity and mortality and health disparities. Mindfulness interventions have been shown to decrease stigma and the negative impacts of stigma, however, these interventions have never been tested to decrease lung cancer stigma specifically. In this study, the investigators will use Community Based Participatory Research framework and MOST methodology to build and optimize a brief virtual mindfulness intervention to decrease lung cancer stigma, through first building a diverse coalition of lung cancer patients on a participatory action council.

Primary Outcome

Both perceived/felt stigma (negative appraisal and devaluation from others) and internalized/self (internalization of perceived stigma) stigma from having lunch cancer.

Interventions

  • BEHAVIORAL Ultra-brief mindfulness intervention video
  • BEHAVIORAL Forgiveness video
  • BEHAVIORAL ACT values video

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2024-07-31
Est. Completion 2026-04-13
Phase NA

What the finished NCT06286592 record still lists

NCT06286592 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 3 interventions - of which Ultra-brief mindfulness intervention video is the first listed.

NCT06286592 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06286592 about?

NCT06286592 is a clinical study titled "LUNGevity: Lung Cancer Stigma Community Based Participatory Research". Lung cancer survival rates are low for intersectional underserved groups. Lung cancer stigma and intersectional stigma related to minoritized group status leads to increased morbidity and mortality and health disparities. Mindfulness interventions have been shown to decrease stigma and the negative ...

What is the current status of trial NCT06286592?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2024-07-31. Estimated completion is 2026-04-13.

What interventions are being tested in trial NCT06286592?

The interventions under investigation include: Ultra-brief mindfulness intervention video (BEHAVIORAL), Forgiveness video (BEHAVIORAL), ACT values video (BEHAVIORAL).

Who is sponsoring clinical trial NCT06286592?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06286592's enrollment target sits among peer trials

108 825th of 2000 higher than 1,171 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06286592, the US trial registry maintained by the National Library of Medicine. NCT06286592 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.